Instil Bio (TIL) Change in Account Payables (2020 - 2026)
Instil Bio (TIL) posted quarterly Change in Account Payables of $17000.0 for Q1 2026, up 104.52% year-over-year from $8312.1 in Q1 2025, and up 111.49% quarter-over-quarter from -$148000.0 in Q4 2025.
Instil Bio (TIL) Change in Account Payables (2020 - 2026) Analysis & Trends
Instil Bio's Change in Account Payables history runs 7 years deep, the most recent figure standing at $17000.0 for Q1 2026.
- In Q1 2026, Change in Account Payables rose 104.52% year-over-year to $17000.0; the TTM figure through Mar 2026 stood at $509000.0 (up 153.47% YoY), while the FY2025 annual figure was $116000.0, up 120.86% from the prior year.
- Change in Account Payables for Q1 2026 stood at $17000.0, up from -$148000.0 in the prior quarter.
- The five-year high for Change in Account Payables was $4.1 million in Q2 2022, with the low at -$3.2 million in Q1 2022.
- The 5-year median for Change in Account Payables is -$148000.0 (2025), against an average of -$197529.4.
- The sharpest annual moves came in 2022 and 2025: Change in Account Payables slumped 2322.32% in 2022, then surged 2733.33% in 2025.
- Instil Bio's Change in Account Payables stood at -$2.5 million in 2022, then soared by 80.84% to -$477000.0 in 2023, then slipped by 9.43% to -$522000.0 in 2024, then soared by 71.65% to -$148000.0 in 2025, then soared by 111.49% to $17000.0 in 2026.
- Business Quant data shows TIL's Change in Account Payables at $17000.0 in Q1 2026, -$148000.0 in Q4 2025, and $403000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -8.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 37.53 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Instil Bio | 51.68 Mn | 51.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17,000.00 |
| Mar 31, 2026 | 17,000.00 |
| Dec 31, 2025 | -148,000.00 |
| Dec 31, 2025 | -148,000.00 |
| Sep 30, 2025 | 403,000.00 |
| Sep 30, 2025 | 403,000.00 |
| Jun 30, 2025 | 237,000.00 |
| Jun 30, 2025 | 237,000.00 |
| Mar 31, 2025 | -376,000.00 |
| Mar 31, 2025 | -376,000.00 |
| Dec 31, 2024 | -522,000.00 |
| Dec 31, 2024 | -522,000.00 |
| Sep 30, 2024 | -45,000.00 |
| Sep 30, 2024 | -45,000.00 |
| Jun 30, 2024 | -9,000.00 |
| Jun 30, 2024 | -9,000.00 |
| Mar 31, 2024 | 20,000.00 |
| Mar 31, 2024 | 20,000.00 |
| Dec 31, 2023 | -477,000.00 |
| Dec 31, 2023 | -477,000.00 |